Caption Management, LLC Novavax Inc Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $2.57 Million - $4.11 Million	240,000 New	240,000 $3.03 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $2.43 Million - $5.18 Million	-20,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $2.27 Million - $6.43 Million	20,100 New	20,100 $3.64 Million
Q1 2020 May 15, 2020	SELL	$3.93 - $16.0 $2.67 Million - $10.9 Million	-680,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.02 - $7.84 $1 Million - $1.96 Million	-250,000 Reduced 26.88%	680,000 $3.41 Million
Q2 2019 Aug 13, 2019	BUY	$4.93 - $12.2 $4.58 Million - $11.3 Million	930,000 New	930,000 $5.45 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.